Mitogen-Activated Protein Kinases and Reactive Oxygen Species: How Can ROS Activate MAPK Pathways?

Yong Son1, Yong-Kwan Cheong, Nam-Ho Kim

  • 1Department of Anesthesiology and Pain Medicine, Wonkwang University School of Medicine, Iksan 570-749, Republic of Korea.

Insights

Reactive oxygen species (ROS) activate mitogen-activated protein kinase (MAPK) pathways through unclear mechanisms. This review explores how oxidative modifications and MAPK phosphatase inactivation by ROS may explain MAPK pathway activation during oxidative stress.

Area of Science:

  • Cellular signaling
  • Molecular biology
  • Biochemistry

Background:

  • Mitogen-activated protein kinases (MAPKs) are key regulators of signal transduction.
  • MAPK pathways involve a three-kinase module (MAP3K, MAP2K, MAPK) and are modulated by MAPK phosphatases (MKPs).
  • Oxidative stress, induced by reactive oxygen species (ROS), is known to activate MAPK pathways.

Purpose of the Study:

  • To review the mechanisms by which ROS activate MAPK pathways.
  • To elucidate the roles of oxidative modifications and MKP inactivation in ROS-induced MAPK activation.

Main Methods:

  • Literature review of studies on MAPK signaling and oxidative stress.
  • Analysis of proposed mechanisms for ROS-mediated MAPK activation.

Main Results:

  • Increased ROS production generally leads to the activation of ERKs, JNKs, or p38 MAPKs.
  • Plausible mechanisms for ROS-induced MAPK activation include oxidative modifications of MAPK signaling proteins and inactivation/degradation of MKPs.

Conclusions:

  • Oxidative modifications and MKP inactivation are likely key mechanisms underlying ROS-induced MAPK pathway activation.
  • Understanding these mechanisms is crucial for comprehending cellular responses to oxidative stress.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...